loading...| Preferred Name |
Fosinopril Sodium |
|
| Synonyms |
|
|
| Definitions |
The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C47542 |
|
| CAS_Registry |
88889-14-9 |
|
| CHEBI_ID |
CHEBI:5164 |
|
| Chemical_Formula |
C30H45NO7P.Na |
|
| code |
C47542 |
|
| Contributing_Source |
FDA |
|
| definition |
The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05) |
|
| FDA_UNII_Code |
NW2RTH6T2N |
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset | ||
| label |
Fosinopril Sodium |
|
| Legacy Concept Name |
Fosinopril_Sodium |
|
| Preferred_Name |
Fosinopril Sodium |
|
| prefixIRI |
NCIT:C47542 |
|
| prefLabel |
Fosinopril Sodium |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0733440 |
|
| subClassOf |